Regulation of O-Linked N-Acetyl Glucosamine Transferase (OGT) through E6 Stimulation of the Ubiquitin Ligase Activity of E6AP.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
24 Sep 2021
Historique:
received: 29 07 2021
revised: 17 09 2021
accepted: 21 09 2021
entrez: 13 10 2021
pubmed: 14 10 2021
medline: 3 11 2021
Statut: epublish

Résumé

Glycosyltransferase OGT catalyzes the conjugation of O-linked β-D-N-acetylglucosamine (O-GlcNAc) to Ser and Thr residues of the cellular proteins and regulates many key processes in the cell. Here, we report the identification of OGT as a ubiquitination target of HECT-type E3 ubiquitin (UB) ligase E6AP, whose overexpression in HEK293 cells would induce the degradation of OGT. We also found that the expression of E6AP in HeLa cells with the endogenous expression of the E6 protein of the human papillomavirus (HPV) would accelerate OGT degradation by the proteasome and suppress O-GlcNAc modification of OGT substrates in the cell. Overall, our study establishes a new mechanism of OGT regulation by the ubiquitin-proteasome system (UPS) that mediates the crosstalk between protein ubiquitination and O-GlcNAcylation pathways underlying diverse cellular processes.

Identifiants

pubmed: 34638625
pii: ijms221910286
doi: 10.3390/ijms221910286
pmc: PMC8508608
pii:
doi:

Substances chimiques

Oncogene Proteins, Viral 0
Ubiquitin 0
UBE3A protein, human EC 2.3.2.26
Ubiquitin-Protein Ligases EC 2.3.2.27
N-Acetylglucosaminyltransferases EC 2.4.1.-
OGT protein, human EC 2.4.1.255
Proteasome Endopeptidase Complex EC 3.4.25.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Natural Science Foundation of China
ID : 31770921;31971187
Organisme : Science and Technology Commission of Shanghai Municipality Project
ID : 20JC1411200
Organisme : NIH HHS
ID : R01GM104498
Pays : United States
Organisme : National Science Foundation
ID : 1710460; 2109051

Références

FASEB J. 2020 Nov;34(11):14473-14489
pubmed: 32892442
Nat Cell Biol. 2006 Oct;8(10):1074-83
pubmed: 16964247
J Biol Chem. 2014 Apr 11;289(15):10592-10606
pubmed: 24563466
Mol Cell. 2010 Jun 11;38(5):700-11
pubmed: 20542002
J Biol Chem. 2019 Apr 26;294(17):6843-6856
pubmed: 30858176
J Virol. 2000 Jul;74(14):6408-17
pubmed: 10864652
EMBO J. 2010 Nov 17;29(22):3787-96
pubmed: 20959806
Annu Rev Biochem. 2001;70:503-33
pubmed: 11395416
Biochim Biophys Acta. 2010 Feb;1800(2):96-106
pubmed: 19647786
Proc Natl Acad Sci U S A. 2011 May 17;108(20):8146-51
pubmed: 21540332
Nat Rev Cancer. 2011 Aug 18;11(9):678-84
pubmed: 21850036
Cell. 2009 Apr 3;137(1):133-45
pubmed: 19345192
Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6611-6
pubmed: 11371615
Chem Biol. 2012 Oct 26;19(10):1265-77
pubmed: 23102221
Oncotarget. 2016 Jul 12;7(28):44596-44607
pubmed: 27331873
Mol Cell Proteomics. 2013 Dec;12(12):3489-97
pubmed: 23824911
Annu Rev Biochem. 1998;67:425-79
pubmed: 9759494
Virology. 2013 Jan 20;435(2):357-62
pubmed: 23206439
J Biomed Sci. 2012 Feb 02;19:12
pubmed: 22300411
J Virol. 2009 Apr;83(8):3704-18
pubmed: 19193796
Cell Chem Biol. 2021 Sep 16;28(9):1283-1297.e8
pubmed: 33667410
Nucleic Acids Res. 2019 Jan 8;47(D1):D433-D441
pubmed: 30445427
Biochem Biophys Res Commun. 2016 Mar 18;471(4):539-44
pubmed: 26876577
EMBO J. 1987 Jan;6(1):139-44
pubmed: 3034571
Nat Struct Mol Biol. 2011 May;18(5):520-8
pubmed: 21540891
Nat Commun. 2017 Dec 20;8(1):2232
pubmed: 29263404
Oncogene. 2016 Apr 21;35(16):2062-74
pubmed: 26234678
Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):9872-7
pubmed: 26216987
Pharmacol Rev. 2020 Apr;72(2):380-413
pubmed: 32107274
Cardiovasc Res. 2014 Jul 1;103(1):131-9
pubmed: 24788415
Am J Physiol Cell Physiol. 2012 Jun 15;302(12):C1786-96
pubmed: 22496241
Biochim Biophys Acta. 2013 Dec;1833(12):2682-2689
pubmed: 23777819
Mol Biosyst. 2007 Nov;3(11):766-72
pubmed: 17940659
Trends Endocrinol Metab. 2008 Dec;19(10):380-9
pubmed: 18929495
Nat Rev Mol Cell Biol. 2017 Jul;18(7):452-465
pubmed: 28488703
Theranostics. 2021 Jan 1;11(2):805-823
pubmed: 33391506
Cell. 2003 Dec 12;115(6):715-25
pubmed: 14675536
Glycobiology. 2013 Oct;23(10):1114-30
pubmed: 23580777
Nat Rev Mol Cell Biol. 2012 Apr 23;13(5):312-21
pubmed: 22522719
Sci Adv. 2018 Jan 03;4(1):e1701393
pubmed: 29326975
Virology. 2013 Oct;445(1-2):115-37
pubmed: 23711382
Cell Death Dis. 2020 Sep 29;11(9):815
pubmed: 32994395
Mol Cell. 2015 Apr 2;58(1):47-59
pubmed: 25773598
Biochemistry. 1995 Feb 7;34(5):1686-94
pubmed: 7849028
Proc Natl Acad Sci U S A. 2016 Aug 16;113(33):9333-8
pubmed: 27482104
Annu Rev Biochem. 2011;80:825-58
pubmed: 21391816
Cell Mol Bioeng. 2016 Jun;9(2):227-233
pubmed: 28638491

Auteurs

Kangli Peng (K)

Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.
Department of Chemistry, Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, GA 30303, USA.

Ruochuan Liu (R)

Department of Chemistry, Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, GA 30303, USA.

Caiwei Jia (C)

Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 100864, China.

Yiyang Wang (Y)

Department of Pathophysiology, School of Medicine, Jinan University, Guangzhou 510632, China.

Geon H Jeong (GH)

Department of Chemistry, Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, GA 30303, USA.

Li Zhou (L)

Department of Chemistry, Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, GA 30303, USA.

Ronggui Hu (R)

Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 100864, China.

Hiroaki Kiyokawa (H)

Department of Pharmacology, Northwestern University, Chicago, IL 60611, USA.

Jun Yin (J)

Department of Chemistry, Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, GA 30303, USA.

Bo Zhao (B)

Engineering Research Center of Cell and Therapeutic Antibody, Ministry of Education, School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH